Vir Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

Vir Biotechnology

03/08/2023 22:43

* Vir Biotechnology Inc  VIR.OQ  reported a quarterly
adjusted
loss of $1.45​​ per share for the quarter ended in June. The
mean expectation of nine analysts for the quarter was for a loss
of $1.20 per share.
    * Revenue was $3.80 million​; analysts expected $25.89
million. 
    * Vir Biotechnology Inc's reported EPS for the quarter was a
loss
of $1.45​.
    * The mean earnings estimate of analysts had fallen by
about 12.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Vir Biotechnology Inc shares had fallen by 42.8% this
quarter and lost 44.5% so far this year.
    * The company reported a quarterly loss of $194.78 million.
    * Wall Street's median 12-month price target for Vir
Biotechnology
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.20          -1.45          Missed
 Mar. 31 2023      -0.87          -1.06          Missed
 Dec. 31 2022      -0.39          -0.76          Missed
 Sep. 30 2022      -0.21          1.30           Beat